Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China flag China · Delayed Price · Currency is CNY
6.27
+0.07 (1.13%)
Feb 3, 2026, 3:00 PM CST

SHA:600613 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
611.09779.39715.28656.49493.8481.49
Trading Asset Securities
210.6520.8720.9---
Cash & Short-Term Investments
821.74800.27736.17656.49493.8481.49
Cash Growth
-5.99%8.71%12.14%32.95%2.56%-19.22%
Accounts Receivable
510.55529.62750.25813.82675.75652.71
Other Receivables
10.074.89.7411.0920.3829.67
Receivables
520.62534.42759.99824.91696.12682.38
Inventory
218.95228.34242.86218.82205.13203.7
Other Current Assets
28.832.8833.2369.6750.863.71
Total Current Assets
1,5901,5961,7721,7701,4461,431
Property, Plant & Equipment
1,0341,0541,0521,1001,167960.14
Long-Term Investments
86.7287.0274.1467.3383.0884.67
Goodwill
243.85243.85243.85299.06299.06299.06
Other Intangible Assets
94.7596.6595.298.91104.81110.66
Long-Term Accounts Receivable
-----148.63
Long-Term Deferred Tax Assets
24.8423.1723.4436.0228.8350.59
Long-Term Deferred Charges
1.111.641.631.852.33.95
Other Long-Term Assets
10.3913.2116.6612.8518.138.99
Total Assets
3,0863,1163,2793,3863,1493,098
Accounts Payable
242.43223.85249.85186.8188.31150.75
Accrued Expenses
13.1629.2131.9849.7625.8924.12
Short-Term Debt
3227.031821.082.722.72
Current Portion of Long-Term Debt
42.5140.7436.9235.6836-
Current Portion of Leases
-9.3311.028.6615.74-
Current Income Taxes Payable
27.425.112.247.910.0425.55
Current Unearned Revenue
64.0735.429.6782.8345.0629.01
Other Current Liabilities
112.21160.21306.36381.62156.04225.25
Total Current Liabilities
533.78530.88686.04774.34479.81457.39
Long-Term Debt
116.74129.58170.1207.7242.9285.5
Long-Term Leases
2.810.4517.0312.4814.924.05
Long-Term Unearned Revenue
5.451.651.261.533.026.98
Long-Term Deferred Tax Liabilities
18.0116.4514.3418.2415.8116.36
Total Liabilities
676.78689.01888.771,014756.45770.28
Common Stock
534.07534.07534.07534.07534.07534.07
Additional Paid-In Capital
968.99968.99968.99968.99968.99969.34
Retained Earnings
799.43829.24811.25807.79813.1743.48
Comprehensive Income & Other
30.5230.7421.0716.2628.1230.48
Total Common Equity
2,3332,3632,3352,3272,3442,277
Minority Interest
76.463.7755.1844.7348.2350.32
Shareholders' Equity
2,4092,4272,3912,3722,3932,328
Total Liabilities & Equity
3,0863,1163,2793,3863,1493,098
Total Debt
194.05217.13253.07285.61312.28292.26
Net Cash (Debt)
627.69583.14483.11370.88181.52189.22
Net Cash Growth
-0.71%20.71%30.26%104.32%-4.07%25.71%
Net Cash Per Share
1.111.060.930.690.340.35
Filing Date Shares Outstanding
534.07534.07534.07534.07534.07534.07
Total Common Shares Outstanding
534.07534.07534.07534.07534.07534.07
Working Capital
1,0561,0651,086995.55966.05973.89
Book Value Per Share
4.374.424.374.364.394.26
Tangible Book Value
1,9942,0231,9961,9291,9401,868
Tangible Book Value Per Share
3.733.793.743.613.633.50
Buildings
-1,0021,0011,001978.49-
Machinery
-651.9651.59643.1607.56-
Construction In Progress
-141.2563.9553.8358.26-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.